US Edition
Analysis Supports Flexible Axatilimab Use in Chronic GVHD, Calls for Combination Therapy Research: Carrie Kitko, MD
Summary by ajmc.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Analysis Supports Flexible Axatilimab Use in Chronic GVHD, Calls for Combination Therapy Research: Carrie Kitko, MD
Carrie Kitko, MD, explains that axatilimab maintains strong response rates in patients with chronic graft-versus-host disease (GVHD) regardless of previous treatment lines and emphasizes the need to explore combination therapies.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
